Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.
AUTOR(ES)
Shen, D W
RESUMO
Inducer-mediated murine erythroleukemia cell (MELC) differentiation provides a model for examining factors determining terminal cell differentiation. The nuclear protein, p53, has been implicated as a potential determinant of cell cycle progression and cell differentiation. In this study p53 content and synthesis, during inducer-mediated MELC differentiation, has been examined with monoclonal antibodies to p53. A decrease in p53 synthesis and content was demonstrated during induced differentiation. As determined by cell cycle fractionation, the decrease in p53 is manifest at all stages of the cell cycle. Hemin, which induces globin mRNA accumulation but not terminal cell division, fails to decrease p53 content. A MELC variant resistant to inducer-mediated commitment to terminal cell division also fails to decrease p53 levels in response to inducers. These experiments suggest that p53 is implicated in MELC cell proliferation and that an induced decrease in p53 may be responsible for G1 phase prolongation and terminal G1 arrest.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=390188Documentos Relacionados
- Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
- Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
- Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division.
- Hexamethylenebisacetamide-resistant murine erythroleukemia cells have altered patterns of inducer-mediated chromatin changes.
- Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.
